Page last updated: 2024-08-25

rosiglitazone and Carcinogenesis

rosiglitazone has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goepfert, C; Hafner, J; Jandus, C; Levesque, MP; Loyon, R; Mastelic-Gavillet, B; Meylan, P; Michalik, L; Moret, C; Moser, H; Nguyen, TN; Pich, C; Romero, P; Trang, BK	1

Other Studies

1 other study(ies) available for rosiglitazone and Carcinogenesis

Article	Year
Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth. Cancer research, 2018, 11-15, Volume: 78, Issue:22 Topics: Angiogenesis Inducing Agents; Animals; Carcinogenesis; Cell Line, Tumor; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Monocytes; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Paracrine Communication; PPAR gamma; Rosiglitazone; Skin Neoplasms; Stromal Cells; T-Lymphocytes	2018

Article

Year

Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth.

Cancer research, 2018, 11-15, Volume: 78, Issue:22

Topics: Angiogenesis Inducing Agents; Animals; Carcinogenesis; Cell Line, Tumor; Fibroblasts; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Melanoma; Mice; Mice, Inbred NOD; Mice, SCID; Monocytes; Neoplasm Metastasis; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Paracrine Communication; PPAR gamma; Rosiglitazone; Skin Neoplasms; Stromal Cells; T-Lymphocytes

2018